Skip to main navigation Skip to search Skip to main content

Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age

Translated title of the contribution: Pharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age
  • D.M. Burger
  • , A.M.C. van Rossum
  • , P.W.H. Hugen
  • , M.H. Suur
  • , N.G. Hartwig
  • , S.P.M. Geelen
  • , H.J. Scherpbier
  • , R.M.W. Hoetelmans
  • , A.G. Vulto
  • , T. Berglund

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPharmacokinetics of the protease inhibitor indinivavir in human immunodeficiency virus type 1-infected children treated with highly active antiretroviral therapy is better than in adults and independent of age
Original languageUndefined/Unknown
Pages (from-to)701-705
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume45
Issue number3
Publication statusPublished - 2001

Cite this